Fox Run Management L.L.C. increased its stake in shares of Enhabit, Inc. (NYSE:EHAB – Free Report) by 290.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 42,237 shares of the company’s stock after acquiring an additional 31,412 shares during the quarter. Fox Run Management L.L.C. owned approximately 0.08% of Enhabit worth $330,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other large investors have also bought and sold shares of the stock. Jane Street Group LLC grew its holdings in shares of Enhabit by 514.3% in the third quarter. Jane Street Group LLC now owns 901,084 shares of the company’s stock worth $7,119,000 after purchasing an additional 754,395 shares during the last quarter. Paradice Investment Management LLC grew its holdings in Enhabit by 12.8% in the 4th quarter. Paradice Investment Management LLC now owns 1,780,113 shares of the company’s stock worth $13,903,000 after acquiring an additional 201,997 shares during the last quarter. Systematic Financial Management LP increased its position in shares of Enhabit by 12.2% in the third quarter. Systematic Financial Management LP now owns 1,838,199 shares of the company’s stock valued at $14,522,000 after acquiring an additional 199,235 shares during the period. Bardin Hill Management Partners LP raised its stake in shares of Enhabit by 927.4% during the third quarter. Bardin Hill Management Partners LP now owns 174,304 shares of the company’s stock valued at $1,377,000 after acquiring an additional 157,338 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Enhabit by 37.8% during the third quarter. JPMorgan Chase & Co. now owns 305,245 shares of the company’s stock valued at $2,411,000 after acquiring an additional 83,707 shares during the last quarter.
Enhabit Trading Down 0.5 %
NYSE:EHAB opened at $8.80 on Thursday. The company has a 50-day moving average price of $8.47 and a 200-day moving average price of $7.96. The stock has a market cap of $444.22 million, a price-to-earnings ratio of -3.79 and a beta of 1.80. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. Enhabit, Inc. has a 12 month low of $6.85 and a 12 month high of $11.74.
Analyst Ratings Changes
Get Our Latest Stock Report on Enhabit
Enhabit Company Profile
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
See Also
- Five stocks we like better than Enhabit
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Energy Transfer: Powering Data With Dividends and Diversification
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Qualcomm Stock Is Coiling for a Breakout
- Best Stocks Under $5.00
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB – Free Report).
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.